Abstract # 2142 Phase II Study with Oral Capecitabine (XELODAr) as a Radiosensitiser in Neoadjuvant Treatment of Locally Advanced Rectal Cancer

Presenter: Anderluh, Franc

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

V. Velenik*, F. Anderluh*, I. Oblak*, P. Strojan*, B. Zakotnik*. , Institute of Oncology, Ljubljana, Slovenia,

Author Disclosure:
V. Velenik, None; F. Anderluh, None; I. Oblak, None; P. Strojan, None; B. Zakotnik, None.

E-mail a friend about this abstract:
Enter email address:   

Abstracts Main Page | Logout